The importance of a collagen-binding adhesin in the pathogenesis of septic arthritis has been examined by comparing the virulence of two sets of Staphylococcus aureus mutants in an animal model. Collagen adhesin-negative mutant PH100 was constructed by replacing the chromosomal collagen adhesin gene (cna) in a clinical strain, Phillips, with an inactivated copy of the gene. Collagen adhesin-positive mutant S. aureus CYL574 was generated by introducing the cna gene into CYL316, a strain that normally lacks the cna gene. Biochemical, immunological, and functional analyses of the generated mutants and their respective parent strains showed that binding of 1251-labeled collagen, expression of an immunoreactive collagen adhesin, and bacterial adherence to cartilage were directly correlated with the presence of a functional cna gene. Greater than 70% of the mice injected with the Cna+ strains developed clinical signs of arthritis, whereas less than 27% of the animals injected with Cna-strains showed symptoms of disease. Furthermore, mice injected with the Cna+ strain Phillips had remarkably elevated levels of immunoglobulin Gl and interleukin-6 compared with mice injected with the Cna-mutant PH100. Taken together, these results demonstrate that collagen adhesin plays an important role in the pathogenesis of septic arthritis induced by S. aureus.
Hematogenously acquired bacterial arthritis remains a serious medical problem. This rapidly progressive and highly destructive joint disease is difficult to eradicate, with less than 50% of the infected patients recovering without serious joint damage. Staphylococcus aureus is the most common etiological agent of both bacterial arthritis and acute osteomyelitis, causing up to 80% of the cases (7, 27 ).
An analysis of S. aureus strains isolated from patients diagnosed with osteomyelitis and septic arthritis revealed that almost all of the isolates contained a collagen-binding adhesin (24) . In contrast, only one-third of the S. aureus strains isolated from patients with soft tissue infections expressed the collagen adhesin (24) .
We have previously isolated a collagen-binding protein from the cell surface of S. aureus (22) and shown that this protein can act as an adhesin, mediating the attachment of S. aureus cells to cartilage (24) . Furthermore, cloning and sequencing of the collagen adhesin gene, cna, from S. aureus FDA 574 has revealed a protein that can occur in at least two forms, with molecular masses of approximately 135 and 110 kDa, in different strains. A recombinant form of the adhesin inhibited the binding of S. aureus to soluble type II collagen (22) and the attachment of S. aureus cells to cartilage (24) .
To determine the importance of the collagen adhesin as a virulence factor in staphylococcus-induced septic arthritis, we have constructed two classes of mutants. In the first class of mutants, the isolated collagen adhesin gene, cna, was inactivated in an S. aureus clinical isolate obtained from a patient with osteomyelitis. In the second type of mutant, the intact cna gene was introduced into an S. aureus strain that lacked the gene.
We have compared the virulence of the two classes of S. aureus mutants with that of their respective parent strains using a newly developed and characterized murine model of septic arthritis (4, 5) . In this model, mice display histopathological signs of arthritis peaking approximately 2 to 3 weeks postinjection, with regard to both intensity and extension of arthritis, and leveling off thereafter. Clinically estimated signs of arthritis correlate closely to the histopathological evaluation (4) . Tail lesions with inflammatory cells invading and destroying the disk and the bone tissue occur within 4 weeks after inoculation in approximately 50% of the mice. Furthermore, the arthritic mice often display a tremendous interleukin-6 (IL-6)-driven polyclonal B-cell activation (1, 4) .
The results presented show that mice injected intravenously (i.v.) with S. aureus strains expressing the collagen adhesin were much more likely to develop arthritis compared with mice injected with the S. aureus mutant strains. Moreover, levels of immunoglobulin Gl (IgGl) and IL-6 in serum were dramatically elevated in mice injected with the Cna+ clinical isolate compared with levels in serum in mice injected with the Cna-mutant or saline. Taken together these data demonstrate that the collagen adhesin is an important virulence factor in septic arthritis induced by staphylococci.
MATERIALS AND METHODS
Abbreviations. The following abbreviations are used in this paper: BHI, brain heart infusion; BSA, bovine serum albumin; EY, egg yolk; GM, gentamicin; PBS, phosphatebuffered saline; PBST, PBS containing Tween 20; and SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis. (12) . Human thrombospondin purified from activated human platelets as previously described (19) was a gift from Joanne Murphy-Ullrich, University of Alabama, Birmingham. The 29-kDa fragment of human fibronectin was generated by thermolysin digestion of intact fibronectin and isolated as described by McGavin and colleagues (18) . Collagen, fibrinogen, and the 29-kDa fragment of fibronectin were labeled with "2I by the chloramine-T method (10) . Thrombospondin was labeled with 1251I by using Enzymobeads (Bio-Rad, Richmond, Calif.). Na125I (specific activity, 15 mCi/,ug) was obtained from Amersham Corp., Arlington Heights, Ill. The estimated specific activities of the radiolabeled ligands ranged from 2 x 106 to 5 x 107 cpm/,lg of protein.
Isolation of the collagen adhesin gene. Genomic DNA was isolated from S. aureus cells as previously described (16) . Different forms of the cna gene were generated by using PCR and genomic DNA from S. aureus FDA 574 as the template. Oligonucleotides (Oligo's Etc., Guilford, Conn.) CNA-I (5' CCGAAT=CGCACTTfGTATTCGTTATAC 3') and CNA-II (5' ATICTGCAGAGAACTAAGAATAGCCTT 3') were used to amplify the entire cna gene as previously described (22, 24 proteins. The amount of 125I-labeled protein bound to bacteria was quantified essentially as described previously (25) . All assays were done in duplicate.
SDS-PAGE and Western blot analysis. Lysostaphin cell surface extracts were prepared from the S. aureus strains and subjected to SDS-PAGE and Western blot (immunoblot) analysis as described earlier (22, 24, 25) .
Biotin labeling of S. aureus cells and cartilage attachment assays. S. aureus strains were cultured under constant rotation for 15 A modification of the attachment assay as described previously (24) (20) . The cna gene from S. aureus FDA 574 encoding the cell surface collagen adhesin protein was amplified by PCR and inactivated by inserting a gentamicin resistance determinant within the coding sequence of the cna structural gene as described in Materials and Methods. Plasmid pBLGM574, containing the interrupted cna gene, was ligated to a DNA fragment containing an S. aureus temperature-sensitive origin of replication to create pBLGM574,s, as schematically diagrammed in Fig. 1 . Plasmid pBLGM574t, was subsequently introduced into S. aureus Phillips, a strain isolated from a patient with osteomyelitis. Initially, the transformed cells were grown at 30°C to expand the culture of plasmid-containing cells. The temperature was then shifted to 42°C to promote chromosomal incorporation of the recombinant plasmid and to allow allele replacement of the intact chromosomal copy of the cna gene with the cna::Gm mutation. One such mutant, PH100, first identified by its resistance to gentamicin, was isolated and further characterized.
A collagen adhesin-positive mutant was constructed through incorporation of a single copy of the cna gene into the chromosome of a cna-negative S. aureus strain. This was accomplished by cloning the PCR-amplified cna gene from S. aureus FDA 574 into the single-copy integration vector pCL84 to create plasmid pCL574, depicted in Fig. 2 . This vector integrates into the S. aureus chromosome at the L54a attB site by site-specific recombination (13) . The attB site is close to the 3' end of the structural gene for a lipase (geh) (21) , and integration into this site causes a loss of lipase production (14) . Parent strain CYL316 had detectable lipase activity, as evidenced by the halo of precipitated calcium salts of hydrolzed fatty acids surrounding the isolated colonies when plated and grown on egg yolk-containing medium (see Fig.  4B ). Conversely, mutant strain CYL574 appears to have lost lipase activity, as is evident when these cells were plated on the same medium (see Fig. 4B ). This strain was further characterized.
Southern hybridization analysis of the collagen adhesin mutants. Genomic DNA from parent strain Phillips and its isogenic derivative PH100 were digested with EcoRI and PstI and probed with a random-primed PCR-amplified fragment of the cna gene. A single 5.5-kb band in Phillips DNA hybridized to the 333-bp cna probe (Fig. 3A, lane 1) , whereas the probe hybridized to an approximately 6.1-kb band in the DNA from the putative collagen adhesin-negative mutant PH100 (Fig. 3A, lane 2) . A 6.1-kb EcoRI-PstI band is predicted on the basis of the restriction fragment pattern of the original plasmid pBLGM574t,, which was used for allele replacement (Fig. 1) . If a single crossover event had occurred, one would expect two hybridizing fragments to be detected in Fig. 3A , lane 2, one from the original copy of the cna gene and one from the interrupted version of the cna gene. During the isolation of the isogenic mutants, several clones that did undergo a single crossover event were isolated, but they were not studied further. In Fig. 3B (Fig. 3B, lanes 1, 3, and 6 ). These data single band in all lanes containagree with the Cna-Gmr phenotype exhibited by PH100 and 00 (Fig. 3B, lanes 2, 4, and 7) , also the Cna+ Gms phenotype of parent strain Phillips. etected with DNA 
isolated from
To genetically analyze the putative S. aureus collagen adhesin-positive mutant, genomic DNA was prepared from parent strain CYL316 and the isolated mutant CYL574. The DNA was cleaved with EcoRI and BamHI and probed with the same 333-bp cna fragment described above. A 3.6-kb 1 2 3 4 5 6 7 band from CYL574 hybridized to the probe (Fig. 4A, lane 3) , indicating that the cna gene had been incorporated into the chromosome, whereas no hybridization was detected with restriction fragments generated from parent strain DNA (Fig. 4A, lane 2) . EcoRI-and BamHI-digested plasmid pCL574, which was used to electroporate the parent strain, yielded a 3.6-kb fragment corresponding to the cna gene that also hybridized to the probe, as shown in Fig. 4A detected. However, immunoreactive bands were not detected in the extracts from the allele replacement mutant PH100 (Fig. 5, lane 6) or the collagen adhesin-negative parent strain CYL316 (lane 7). Furthermore, the molecular masses of the immunoreactive collagen adhesins, 110 and 133 kDa, from Phillips (3.0-kb cna gene) and CYL574 (3.6-kb cna gene from FDA 574), respectively, correlated with the sizes of the genes from which they were expressed (24 shown to bind various amounts of 1251I-labeled fibronectin, fibrinogen, and thrombospondin (Fig. 6) . Conversely, the allele replacement mutant PH100 bound only 0.3% of the added type II collagen, while the relative amount of binding to 1251I-labeled fibronectin, fibrinogen, and thrombospondin remained largely unchanged. The same assay was conducted with S. aureus CYL574 and CYL316. In this case, one would expect to detect collagen-binding activity by the mutant CYL574 and not by parent strain CYL316. As shown in Fig. 6 , the mutant bound approximately 10% of the 1251I-labeled type II collagen added, whereas the parent strain bound only 0.4%. The overall amount of collagen bound by CYL574 is somewhat smaller than that seen by Phillips (Fig. 6) . The integration of the cna gene in the chromosome of CYL574 at a site different from its normal location may affect the level of transcription. Additionally, the regulatory factors may differ from one strain to another, and these may affect the expression of the cna gene. In fact, the amount of collagen bound by different Cna+ strains may vary considerably (6, 9, 24 to S. aureus CYL316 and CYL574 were at very similar levels and are comparable to those seen with S. aureus Phillips and PH100 (Fig. 6) .
Taken together, these binding data indicate that the collagen adhesin on the cell surface of PH100 has been inactivated by the cna::Gm mutation and that a functional collagen adhesin is expressed on the surface of CYL574 cells. Furthermore, the mutation appears to be site specific in that the functional activities of other cell surface proteins expressed by the parent strain were essentially unaffected.
S. aureus attachment to cartilage. Prior studies have indicated that expression of a collagen adhesin is required and sufficient for S. aureus cells to attach to cartilage (24) . The ability of the two parent strains and the adhesin mutants to attach to cartilage was therefore examined. An in vitro attachment assay in which bacterial cells, surface labeled with biotin, were allowed to adhere to slices of bovine nasal cartilage was developed.
During a 4-h incubation, collagen adhesin-positive strains Phillips and CYL574 attached to the cartilage disks at levels 24-and 5-fold greater than that of collagen adhesin-negative strains PH100 and CYL316, respectively (Fig. 7) . Virulence (25) .
(i) Histopathology. When the joints of the mice in the first experiment were analyzed for histopathological signs indicative of septic arthritis (Fig. 8A) , all of the 10 mice inoculated with S. aureus Phillips displayed arthritis; of these, 8 were classified as having erosive arthritis, i.e., they exhibited destruction of joint cartilage and/or underlying bone (Table 2 ). In contrast, only 5 of the 10 mice injected with the isogenic mutant showed histopathological signs of arthritis; of these, 2 were classified as having erosive arthritis (Table  2) . A representative micrograph of a grossly unaffected knee joint of a mouse that was inoculated with S. aureus PH100 is presented in Fig. 8B . Extra-articular manifestations of S. aureus infection such as osteitis and granulomas in the bone marrow adjacent to the joints occurred in eight of the mice inoculated with S. aureus Phillips, compared with one of the mice inoculated with S. aureus PH100 (data not shown). However, distant osteitic lesions occurred in three mice from each group, irrespective of the infecting organism (Table 2) .
(ii) Bacteriology. In the second experiment, two groups of 12 mice each were injected with Phillips and PH100 and 7 mice were injected with saline. The body weights of the mice were monitored. Mice injected with S. aureus Phillips displayed a significantly smaller weight gain over the course of the experiment compared with the mice injected with the isogenic mutant PH100 (Table 3) . Two of the mice injected with S. aureus Phillips died within the first week, but none of the mice inoculated with S. aureus PH100 died. (Table 2) . Osteitic lesions occurred only in two mice injected with the CYL316 (Table 2) . Taken together, our data demonstrate that the Cnastrains PH100 and CYL316 have a reduced capacity to induce septic arthritis compared to the Cna+ strains, Phillips and CYL574. However, Cna-strains still express other putative virulence factors involved in the development of osteitic lesions. Hence the cell surface expression of the collagen adhesin plays an important role as a virulence factor in this murine model of S. aureus-induced septic arthritis.
Serological manifestations during S. aureus arthritis. During the progression of the bacterial infection a dramatic difference in immunoglobulin production between mice injected with parent S. aureus strain Phillips and its isogenic derivative PH100 was detected. Three weeks after injection with the parent strain, mouse serum IgGl levels were sevenfold higher than levels in serum from mice injected with PH100. Levels of IgG3 and IgM in serum were also significantly higher in the Phillips-infected mice. Moreover, serum IL-6 levels were significantly elevated in the mice injected with S. aureus Phillips compared with those in mice injected with the isogenic mutant (Fig. 9 ). These data suggest that an IL-6-driven polyclonal B-cell activation occurs in response to infection with S. aureus strain Phillips (Cna+) but to a much lesser extent as a consequence of exposure to its isogenic mutant PH100 (Cna-).
DISCUSSION
In prior studies we have demonstrated that expression of the collagen adhesin is both necessary and sufficient to mediate the attachment of S. aureus to cartilage (24) . Scanning electron microscopy studies have shown S. aureus cells to be intimately associated with cartilage and bone retrieved from the site of infection (26) . Furthermore, essentially all strains isolated from patients with osteomyelitis and septic arthritis express a collagen adhesin, whereas only one-third of the strains obtained from patients diagnosed with soft tissue infections express the collagen adhesin (24 (8) . Using an animal model that closely mimics human septic arthritis, we have demonstrated that dramatically fewer mice injected with the collagen adhesin-negative isogenic mutant PH100 or strain CYL316 exhibited clinical features and histopathological signs of arthritis compared with mice injected with the Cna+ strain Phillips or mutant strain CYL574, respectively. Also, the mice injected with strain Phillips became more ill; displaying a higher intensity of arthritis and a delayed weight gain compared with the mice injected with strain PH100. Furthermore, levels of IgGl and IL-6 in serum were dramatically elevated in mice injected with S. aureus Phillips compared with those in mice injected with Cna-mutant PH100 or with saline. The molecular basis for the apparent IL-6-driven polyclonal B-cell activation in mice injected with strain Phillips is presently unclear. In preliminary studies, we have not detected similar differences in serum IgGl and IL-6 levels among mice injected with the Cna-strain CYL316 and the Cna+ strain CYL574, respectively (data not shown). It is possible that the level of collagen adhesin expression among the Cna+ strains differs and/or that these strains differ in additional components necessary for the immune response. Alternatively, collagen adhesin-mediated colonization of S. aureus to cartilage or bone tissue in the joint and subsequent bacterial proliferation result in the emergence of high concentrations of a bacterial component, e.g., a toxin that may trigger secretion of IL-6 by synoviocytes. Bacterial strains unable to colonize the joint or to produce the putative toxin at sufficient levels would not induce an inflammatory response.
The wild-type Cna+ strain S. aureus Phillips was frequently recovered from the joint tissue of injected mice, whereas bacteria could not be detected in the joints of mice injected with Cna-isogenic mutant PH100. In view of this observation, it is surprising that the frequency of tail osteitis was not significantly different in mice injected with the Cna+ and Cna-strains. One possible explanation for this finding is the expression of additional bone tissue adhesins such as those recently described capable of binding bone sialoprotein, a glycoprotein specifically localized to bone tissue (17, 23) . The presence of these cell surface proteins may play a role in the bacterial colonization of bone and contribute to the observed osteitis and the residual infective potential seen with the Cna-mutant PH100 and strain CYL316.
Taken together, the data presented in this communication demonstrate that the collagen adhesin plays an important role in the pathogenesis of staphylococcus-induced septic Immunoglobulin and IL-6 concentrations in mouse serum samples. Twenty-one days after i.v. injection of S. aureus Phillips (Cna+) or PH100 (Cna-), the animals were sacrificed and the concentrations of the indicated immunoglobulins and IL-6 in serum were determined as described previously (4, 5) . P values with regard to comparison between S. aureus Phillips and isogenic mutant PH100 were calculated by using Student's t test (*, P < 0.001; +, not significant). arthritis by mediating bacterial colonization of the cartilage surface. Experiments are presently under way to determine whether a recombinant version of the adhesin can be used as a vaccine to protect animals against bone and joint infections.
